Experts Appearing in Episode IV
Otis W. Brawley, MD is professor of medicine of Hematology and Oncology at the Emory University School of Medicine and professor of Epidemiology at the Emory Rollins School of Public Health. He also serves as associate director of the Winship Cancer Institute at Emory University and as director of the Georgia Cancer Center of Excellence at Grady. Dr. Brawley’s interest in the dissemination of medical knowledge has extended to ethical issues and the availability of new knowledge and technologies to socio-economically disadvantaged communities. His work concerning racial differences in patterns of medical care and the similar outcomes among racial and ethnic groups when there is equal treatment is widely cited in medical literature. Prior to Emory, Brawley was assistant director at the National Cancer Institute for its Office of Special Populations Research. He held an appointment in the Division of Cancer Prevention and was an attending physician at Bethesda Naval Hospital and the National Institutes of Health Clinical Center.
Neil Benowtiz, MD, a professor of medicine, psychiatry, and pharmacy at the University of California at San Francisco, is one of the world’s experts on the effects of nicotine and how it is broken down in the blood and removed from the body. His research has helped explain the addictive nature of nicotine and tobacco and the role nicotine and other substances in tobacco smoke play in various diseases. Dr. Benowitz began studying nicotine and its effects on people in 1975 when that area of research was in its infancy. His early investigations showed how nicotine behaves in the blood and how it is metabolized or broken down by the body. Dr. Benowitz’s research has influenced policy and treatment strategies. For example, his research on nicotine addiction among young people contributed to greater restrictions on smoking in schools.
Robert A. Smith, PhD is a cancer epidemiologist and director of Cancer Screening at the National Office of the American Cancer Society (ACS) in Atlanta, Georgia. He also is adjunct professor of Epidemiology at the Emory School of Public Health. Prior to joining the staff at the ACS, he held positions with the Centers for Disease Control and the Boston University School of Public Health. He has served on many national and federal advisory committees and working groups, and is the co-chair of the National Colorectal Cancer Roundtable. Currently, he serves on the Center for Medicare and Medicaid Services Breast Cancer Expert Group, the Centers for Disease Control’s Breast and Cervical Cancer Early Detection and Control Advisory Committee, and he is chair of the Data Safety and Monitoring Committee for the Digital Mammography Trial. In 1995, he was made an Honorary Fellow of the Society of Breast Imaging.
Peter Greenwald, MD, Dr. PH is director of the Division of Cancer Prevention and Control at the National Cancer lnstitute, NIH. Before assuming that position in 1981, he was director of the Cancer Control Bureau, NY State Department of Health; director of the Epidemiology and Disease Control Study Section, of the NIH, and director of the Division of Epidemiology, NYS Dept. of Health.
Bruce Ames, PhD is a professor of Biochemistry and Molecular Biology, University of California, Berkeley , and a senior scientist at Children’s Hospital Oakland Research Institute (CHORI). Among other things, he is the discoverer of the Ames Test, used to detect and determine carcinogens. He is a member of the National Academy of Sciences and was on their Commission on Life Sciences. He was a member of the board of directors of the National Cancer Institute, the National Cancer Advisory Board, from 1976 to 1982. He was the recipient of the General Motors Cancer Research Foundation Prize (1983), the Tyler Environmental Prize (1985), the Gold Medal Award of the American Institute of Chemists (1991), the Glenn Foundation Award of the Gerontological Society of America (1992), the Lovelace Institutes Award for Excellence in Environmental Health Research (1995), the Honda Prize of the Honda Foundation, Japan (1996), the Japan Prize, (1997), the Kehoe Award, American College of Occup. and Environ. Med. (1997), the Medal of the City of Paris (1998), the U.S. National Medal of Science (1998), The Linus Pauling Institute Prize for Health Research (2001), and the American Society for Microbiology Lifetime Achievement Award (2001). His over 450 publications have resulted in his being among the few hundred most-cited scientists (in all fields).
Ross Hammond is an independent consultant based in San Francisco, and an internationally recognized expert in tobacco control. His focus is on the international dimensions of the tobacco epidemic. He has a masters degree in Applied Economics from American University. He is closely associated with the Campaign for Tobacco Free Kids. Before coming to tobacco control, he worked on a number of different international issues, from the reform of the international financial institutions, to the refugees’ crisis in the Horn of Africa, to the role of NGOs in international advocacy. Over the past 15 years he has worked in East Africa, Washington, DC and at UN headquarters in New York.
Lynn Butterly, MD is a gastroenterologist at Dartmouth-Hitchcock Medical Center and an associate professor of medicine at Dartmouth Medical School. She has a special interest in colon cancer, risk assessment for colorectal cancer, and screening for colorectal cancer or polyps. She is well known for her promotion of education for colon cancer screening. Dr. Butterly is a graduate of Harvard Medical School and has held teaching appointments at Harvard Medical School, Tufts University School of Medicine, and currently at Dartmouth Medical School.